139 related articles for article (PubMed ID: 34911831)
1. Proceedings of the 2019 Viral Clearance Symposium, Session 5: Viral Inactivation.
Ma J
PDA J Pharm Sci Technol; 2022; 76(4):339-348. PubMed ID: 34911831
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation.
Conley L; Tao Y; Henry A; Koepf E; Cecchini D; Pieracci J; Ghose S
Biotechnol Bioeng; 2017 Apr; 114(4):813-820. PubMed ID: 27800626
[TBL] [Abstract][Full Text] [Related]
3. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
Korneyeva M; Hotta J; Lebing W; Rosenthal RS; Franks L; Petteway SR
Biologicals; 2002 Jun; 30(2):153-62. PubMed ID: 12127317
[TBL] [Abstract][Full Text] [Related]
4. On-column virus inactivation by solvent/detergent treatment for a recombinant biological product.
Polasek D; Flicker A; Fiedler C; Farcet MR; Purtscher M; Kreil TR
Biologicals; 2023 Aug; 83():101693. PubMed ID: 37516085
[TBL] [Abstract][Full Text] [Related]
5. Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations-Virus Filtration/Inactivation.
Kreil TR; Roush D
PDA J Pharm Sci Technol; 2018; 72(5):470-478. PubMed ID: 30030356
[TBL] [Abstract][Full Text] [Related]
6. Assessing detergent-mediated virus inactivation, protein stability, and impurity clearance in biologics downstream processes.
Feroz H; Chennamsetty N; Byers S; Holstein M; Li ZJ; Ghose S
Biotechnol Bioeng; 2022 Apr; 119(4):1091-1104. PubMed ID: 35023152
[TBL] [Abstract][Full Text] [Related]
7. Virus reduction in an intravenous immunoglobulin by solvent/detergent treatment, ion-exchange chromatography and terminal low pH incubation.
Roberts PL; Dunkerley C; Walker C
Biologicals; 2012 Sep; 40(5):345-52. PubMed ID: 22658506
[TBL] [Abstract][Full Text] [Related]
8. Proceedings of the 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation.
Ma J; Kreil TR
PDA J Pharm Sci Technol; 2018; 72(5):511-515. PubMed ID: 30030359
[TBL] [Abstract][Full Text] [Related]
9. Viral inactivation for pH-sensitive antibody formats such as multi-specific antibodies.
Duret A; Duarte L; Cahuzac L; Rondepierre A; Lambercier M; Mette R; Recktenwald A; Giovannini R; Bertschinger M
J Biotechnol; 2024 Mar; 384():45-54. PubMed ID: 38403131
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of viruses using novel protein A wash buffers.
Bolton GR; Selvitelli KR; Iliescu I; Cecchini DJ
Biotechnol Prog; 2015; 31(2):406-13. PubMed ID: 25482293
[TBL] [Abstract][Full Text] [Related]
11. Proceedings of the 2017 Viral Clearance Symposium, Session 6: Ensuring Viral Safety in Continuous Processing.
Johnson SA; Roush D
PDA J Pharm Sci Technol; 2018; 72(5):516-524. PubMed ID: 30030352
[TBL] [Abstract][Full Text] [Related]
12. Enveloped virus inactivation using neutral arginine solutions and applications in therapeutic protein purification processes.
McCue JT; Selvitelli K; Cecchini D; Brown R
Biotechnol Prog; 2014; 30(1):108-12. PubMed ID: 24124172
[TBL] [Abstract][Full Text] [Related]
13. Proceedings of the 2019 Viral Clearance Symposium, Session 1: Viral Clearance Strategies and Case Studies.
Reitz S; Schwantes A
PDA J Pharm Sci Technol; 2022; 76(4):297-305. PubMed ID: 34911829
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a Triton X-100 replacement for virus inactivation.
Luo W; Hickman D; Keykhosravani M; Wilson J; Fink J; Huang L; Chen D; O'Donnell S
Biotechnol Prog; 2020 Nov; 36(6):e3036. PubMed ID: 32533632
[TBL] [Abstract][Full Text] [Related]
15. Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII.
Roberts PL
Biologicals; 2008 Sep; 36(5):330-5. PubMed ID: 18674928
[TBL] [Abstract][Full Text] [Related]
16. Session 1.1: Viral Clearance Using Traditional, Well-Understood Unit Operations: Low pH and Detergent Viral Inactivation.
Ma J; Roush D
PDA J Pharm Sci Technol; 2016 Sep; 70(5):410-416. PubMed ID: 27516488
[No Abstract] [Full Text] [Related]
17. The Use of Bayesian Hierarchical Logistic Regression in the Development of a Modular Viral Inactivation Claim.
Banton D; Vacante D; Bulthuis B; Goldstein J; Wineburg M; Schreffler J
PDA J Pharm Sci Technol; 2019; 73(6):552-561. PubMed ID: 31101710
[TBL] [Abstract][Full Text] [Related]
18. Insights into virus inactivation by polysorbate 80 in the absence of solvent.
Chen D; Luo W; Hoffman J; Huang L; Sandefur S; Hall T; Murphy M; O'Donnell S
Biotechnol Prog; 2020 May; 36(3):e2953. PubMed ID: 31846227
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.
Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Sharifi Z
Hum Antibodies; 2008; 17(3-4):79-84. PubMed ID: 19029665
[TBL] [Abstract][Full Text] [Related]
20. Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC.
Farcet JB; Karbiener M; Zelger L; Kindermann J; Kreil TR
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
